MISMATCH REPAIR DEFICIENT OR MSI-HIGH SOLID TUMORS
Clinical trials for MISMATCH REPAIR DEFICIENT OR MSI-HIGH SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new MISMATCH REPAIR DEFICIENT OR MSI-HIGH SOLID TUMORS trials appear
Sign up with your email to follow new studies for MISMATCH REPAIR DEFICIENT OR MSI-HIGH SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy targets hard-to-treat stomach cancer before surgery
Disease control Not yet recruitingThis study tests two different drug combinations given before surgery for people with a specific genetic type of stomach or gastroesophageal junction cancer (dMMR/MSI-H). The goal is to see if these treatments can completely eliminate the tumor before it is removed. About 30 adul…
Matched conditions: MISMATCH REPAIR DEFICIENT OR MSI-HIGH SOLID TUMORS
Phase: PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 26, 2026 10:57 UTC
-
Stomach cancer mystery: why do some patients resist immunotherapy?
Knowledge-focused Not yet recruitingThis study looks at a specific type of stomach cancer (dMMR/MSI-H) that often responds well to immunotherapy, but about half of patients do not. Researchers want to understand why some patients benefit and others don't, by studying tumor samples before and during treatment. The g…
Matched conditions: MISMATCH REPAIR DEFICIENT OR MSI-HIGH SOLID TUMORS
Phase: PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 10:55 UTC